Assessing Online Interventions for Men's' Mental Health and Wellbeing
- Conditions
- Mental Health Wellness 1
- Registration Number
- NCT02785471
- Lead Sponsor
- University of Maryland, Baltimore
- Brief Summary
The purpose of this study is to test a comprehensive, male-oriented, online screening and referral (Screening for Mental Health; SMH) and male-oriented online information and referral intervention program (Man Therapy; MT) to improve mental health and wellbeing with a focus on prevention of suicide and help-seeking behaviors among middle-aged men. The online programs will be offered together to maximize the effect on reducing suicide behavior and increasing mental health help-seeking behaviors for men. If successful in decreasing suicide behavior and ideation and increasing suicide help-seeking behavior, this intervention could be scaled up to contribute to a reduction in suicide behaviors and deaths across the country.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Male
- Target Recruitment
- 554
- men living in Michigan;
- 25-64 years of age at time of enrollment;
- scoring in the moderate- to high-risk range (or answering positively on Question 9) on the Harvard Department of Psychiatry/NDSD Scale (HANDS), scoring in the moderate- to high-risk range for anger on the DSM-5 Level 1 Cross-Cutting Symptom Measure, or identifying any risk for suicide ideation or behavior on the Columbia-Suicide Severity Rating Sale (C-SSRS); and
- fluent in reading English
- females
- scoring in the low risk range on the Harvard Department of Psychiatry/NDSD Scale (HANDS), scoring in the low risk range for anger on the DSM-5 Level 1 Cross-Cutting Symptom Measure, or not identifying any risk for suicide ideation or behavior on the Columbia-Suicide Severity Rating Sale (C-SSRS); and
- not fluent in reading English
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Change in suicide risk as measured by the Columbia-Suicide Severity Rating Scale-Screen Version Baseline; 2 weeks post randomization; 12 weeks post randomization Change in depression symptoms as measured by The HANDS: Harvard Department of Psychiatry National Depression Screening Day Scale Baseline; 2 weeks post randomization; 12 weeks post randomization
- Secondary Outcome Measures
Name Time Method change in financial situation as measured by two items (J1 and J4) of the 2009 National Financial Capability Study, Financial Industry Regulatory Authority 2 weeks post randomization; 12 weeks post randomization change in attitudes toward help-seeking behavior as measured by the Attitudes Toward Seeking Professional Help short-form 2 weeks post randomization; 12 weeks post randomization change in alcohol use/abuse as measured by the Alcohol Use Disorders Identification Test 2 weeks post randomization; 12 weeks post randomization change in relationship conflicts as measured by the Psychological Aggression Scale 2 weeks post randomization; 12 weeks post randomization change in social support as measured by the Perceived Social Support and/or Conflict scale 2 weeks post randomization; 12 weeks post randomization change in interpersonal needs as measured by the Interpersonal Needs Questionnaire 2 weeks post randomization; 12 weeks post randomization change in drug use/abuse as measured by the National Institute of Drug Abuse Quick Screen 2 weeks post randomization; 12 weeks post randomization change in physical aggression as measured by the Physical Aggression Index scale 2 weeks post randomization; 12 weeks post randomization change in help seeking behavior as measured by the Perceived Stigma and Barriers to Care for Psychological Problems scale 2 weeks post randomization; 12 weeks post randomization change in help seeking behavior as measured by the General Help Seeking Questionnaire 2 weeks post randomization; 12 weeks post randomization change in physical and mental health as measured by the Healthy Days Measures 2 weeks post randomization; 12 weeks post randomization change in anger as measures by the DSM-5 Self Rated Level 1 Cross-Cutting Symptom Measure Baseline; 2 weeks post randomization; 12 weeks post randomization
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
University of Maryland Baltimore
🇺🇸Baltimore, Maryland, United States
University of Maryland Baltimore🇺🇸Baltimore, Maryland, United States
